High-sensitivity C-reactive protein and risk of nontraumatic fractures in the bruneck study

Archives of Internal Medicine

Volumn 166, Issue 22, 2006, Pages 2495-2501

  Schett, Georg ^a,d   Kiechl, Stefan ^b   Weger, Siegfried ^c   Pederiva, Angelo ^c   Mayr, Agnes ^c   Petrangeli, Manuele ^c   Oberhollenzer, Friedrich ^c   Lorenzini, Rolando ^c   Redlich, Kurt ^a   Axmann, Roland ^d   Zwerina, Jochen ^a   Willeit, Johann ^b,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c BRUNECK HOSPITAL   (Italy)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CORTICOSTEROID; COUMARIN; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; SEX HORMONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE METABOLISM; BONE TURNOVER; CALCANEUS; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; FRACTURE; HIP FRACTURE; HUMAN; INCIDENCE; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; VERTEBRA FRACTURE;

ADULT; AGED; BONE DENSITY; C-REACTIVE PROTEIN; FEMALE; FRACTURES, SPONTANEOUS; HIP FRACTURES; HUMANS; INFLAMMATION; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; SPINAL FRACTURES;

EID: 33845474273     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.22.2495     Document Type: Article

References (42)

1. Tillet WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52:561-571.
2. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397.
3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
4. Thorand B, Lowel H, Schneider A, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med. 2003;163:93-99.
5. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 2005;4:371-380.
6. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
7. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalized bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344:23-27.
8. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ. 1993;306:558.
9. Goldring S. Osteoporosis and rheumatic diseases. In: Favus MJ, ed. Primer of the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003:299-301.
10. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis in humans. N Engl J Med. 2002;347:185-192.
11. Schett G, Kiechl S, Redlich K, et al. Soluble RANKL and risk of nontraumatic fracture. JAMA. 2004;291:1108-1113.
12. Kiechl S, Schett G, Wenning G, et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation. 2004;109: 2175-2180.
13. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclrosis: prospective results from the Bruneck study. Circulation. 1997;96:3300-3307.
14. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670-676.
15. Smith-Bindman R, Cummings SR, Steiger P, Genant HK. A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res. 1991;6:25-34.
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
17. D'Agostino RB, Lee M-L, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9:1501-1515.
18. Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med. 2005;352:1611-1613.
19. Nilsson TK, Boman K, Jansson JH, et al. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years. Thromb Res. 2005;116:249-254.
20. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem. 2001;47:444-450.
21. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E; Cholesterol and Recurrent Events (CARE) Investigators. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 1999;100:230-235.
22. Loftus EV Jr, Crowson CS, Sandborn WJ, Tremaine WJ, O'Fallon WM, Melton LJ 3rd. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. Gastroenterology. 2002;123:468-475.
23. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study. Ann Intern Med. 2000;133:795-799.
24. Del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737-2745.
25. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44:2331-2337.
26. Knoflach M, Kiechl S, Mayr A, Willeit J, Poewe W, Wick G. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. Arch Intern Med. 2005; 165:2521-2526.
27. Horikawa E, Matsui T, Arai H, Seki T, Iwasaki K, Sasaki H. Risk of falls in Alzheimer's disease: a prospective study. Intern Med. 2005;44:717-721.
28. Ralston SH, Uitterlinden AG, Brandi ML, et al; GENOMOS Investigators. Large-scale evidence for the effect of COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study [published online ahead of print February 21, 2006]. PLoS Med. doi:10.1371/journal.pmed.0030090. Accessed February 21, 2006.
29. Recker RR, Barger-Lux MJ. The elusive concept of bone quality. Curr Osteoporos Rep. 2004;2:97-100.
30. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986;319:516-518.
31. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289:1504-1508.
32. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999; 402:304-309.
33. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III. Incidence of clinical diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7:221-227.
34. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res. 2002;17:716-724.
35. Ayers M, Prince M, Ahmadi S, Baran DT. Reconciling quantitative ultrasound of the calcaneus with X-ray-based measurements of the central skeleton. J Bone Miner Res. 2000;15:1850-1855.
36. Faulkner KG, McClung MR, Coleman LJ, Kingston-Sandahl E. Quantitative ultrasound of the heel: correlation with densitometric measurements at different skeletal sites. Osteoporos Int. 1994;4:42-47.
37. Stewart A, Kumar V, Reid DM. Long-term fracture prediction by DXA and QUS: a 10-year prospective study. J Bone Miner Res. 2006;21:413-418.
38. Gonnelli S, Cepollaro C, Gennari L, et al. Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men. Osteoporos Int. 2005;16:963-968.
39. Miller PD, Siris ES, Barrett-Connor E, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res. 2002;17:2222-2230.
40. He YQ, Fan B, Hans D, et al. Assessment of a new quantitative ultrasound calcaneus measurement: precision and discrimination of hip fractures in elderly women compared with dual X-ray absorptiometry. Osteoporos Int. 2000;11: 354-360.
41. Bauer DC, Gluer CC, Genant HK, Stone K; Fracture Intervention Trial Research Group. Quantitative ultrasound and vertebral fracture in postmenopausal women. J Bone Miner Res. 1995;10:353-358.
42. Hans D, Dargent-Molina P, Schott AM, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet. 1996;348:511-514.